Bert Malengier‐Devlies
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Immunology top 10%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Immunology 16
- Immune Cell Function and Interaction 7
- IL-33, ST2, and ILC Pathways 5
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 4
-
- Autoimmune and Inflammatory Disorders Research 5
- Co-authors
- Patrick Matthys (15 shared papers)Paul Proost (7 shared papers)Carine Wouters (10 shared papers)Mieke Metzemaekers (6 shared papers)Ghislain Opdenakker (4 shared papers)Tania Mitera (8 shared papers)Lien De Somer (4 shared papers)Mieke Gouwy (4 shared papers)
- Journals
- Frontiers in Immunology (5 papers)European Journal of Immunology (2 papers)Arthritis & Rheumatology (2 papers)The Journal of Immunology (2 papers)iScience (1 paper)
- Partner nations
- BelgiumUnited KingdomNetherlands
In The Last Decade
Bert Malengier‐Devlies
27 papers receiving 855 citations
Bert Malengier‐Devlies's Hit Papers
Peers
Comparison fields: 5 of 92
- Infectious Diseases 319
- Immunology 315
- Hematology 68
- Neurology 87
- Modeling and Simulation 14
Countries citing papers authored by Bert Malengier‐Devlies
This map shows the geographic impact of Bert Malengier‐Devlies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bert Malengier‐Devlies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bert Malengier‐Devlies more than expected).
Fields of papers citing papers by Bert Malengier‐Devlies
This network shows the impact of papers produced by Bert Malengier‐Devlies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bert Malengier‐Devlies. The network helps show where Bert Malengier‐Devlies may publish in the future.
Co-authors
The 25 scholars most cited alongside Bert Malengier‐Devlies, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages Hit paper breakdown → | 2021 | 246 |
| 2 | 2020 | 142 | |
| 3 | 2021 | 48 | |
| 4 | 2021 | 42 | |
| 5 | 2021 | 38 | |
| 6 | 2021 | 37 | |
| 7 | 2019 | 34 | |
| 8 | 2020 | 32 | |
| 9 | 2022 | 32 | |
| 10 | 2023 | 32 | |
| 11 | 2018 | 26 | |
| 12 | 2020 | 26 | |
| 13 | 2023 | 20 | |
| 14 | 2023 | 19 | |
| 15 | 2019 | 18 | |
| 16 | 2022 | 13 | |
| 17 | 2021 | 12 | |
| 18 | 2021 | 8 | |
| 19 | 2021 | 8 | |
| 20 | 2023 | 8 |
About Bert Malengier‐Devlies
Bert Malengier‐Devlies is a scholar working on Immunology, Hematology, Infectious Diseases, Neurology and Immunology and Allergy, having authored 27 papers that have together received 864 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (7 papers), Autoimmune and Inflammatory Disorders Research (5 papers), IL-33, ST2, and ILC Pathways (5 papers), COVID-19 Clinical Research Studies (4 papers), Long-Term Effects of COVID-19 (4 papers), Inflammasome and immune disorders (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Infectious Diseases (319 citations), Immunology (315 citations), Hematology (68 citations), Neurology (87 citations) and Modeling and Simulation (14 citations). Bert Malengier‐Devlies has collaborated with scholars based in Belgium, United Kingdom and Netherlands. Frequent co-authors include Patrick Matthys, Paul Proost, Carine Wouters, Mieke Metzemaekers, Ghislain Opdenakker, Tania Mitera, Lien De Somer, Mieke Gouwy, Jennifer Vandooren and Jessica Vandenhaute. Their work appears in journals such as Frontiers in Immunology, European Journal of Immunology, Arthritis & Rheumatology, The Journal of Immunology and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.